v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net income attributable to The Vita Coco Company, Inc. $ 49,451 $ 22,908 $ 79,925 $ 41,790  
Adjustments required to reconcile net income to cash flows from operating activities:          
Depreciation and amortization     965 408  
Amortization of debt issuance cost     9 6  
(Decrease) increase of provision for credit losses     (829) 608  
Unrealized (gain) on derivative instruments 233 (1,067) (2,594) (3,884)  
Stock-based compensation     8,216 5,148  
Noncash lease expense     935 747  
Changes in operating assets and liabilities:          
Accounts receivable     (50,590) (37,758)  
Inventory     28,309 127  
Prepaid expenses, net supplier advances, and other assets     (7,175) (1,454)  
Accounts payable, accrued expenses, and other liabilities     39,358 6,272  
Net cash provided by operating activities     96,529 12,010  
Cash flows from investing activities:          
Cash paid for property and equipment     (612) (1,508)  
Net cash used in investing activities     (612) (1,508)  
Cash flows from financing activities:          
Proceeds from exercise of stock awards     6,112 977  
Cash paid on notes payable     (3) (5)  
Cash paid to acquire treasury stock (8,503)   (20,008) (10,053) $ (11,269)
Net cash used in financing activities     (13,899) (9,081)  
Effects of exchange rate changes on cash and cash equivalents     (246) 961  
Net increase in cash and cash equivalents     81,772 2,382  
Cash, cash equivalents and restricted cash at beginning of the period [1]     198,154 165,933 165,933
Cash, cash equivalents and restricted cash at end of period [1] $ 279,926 $ 168,315 $ 279,926 $ 168,315 $ 198,154
[1] Includes $1,281 and $1,264 of restricted cash as of December 31, 2025 and 2024, respectively. Includes $1,286 and $1,273 of restricted cash as of June 30, 2026 and 2025, respectively, reported in other current assets on the condensed consolidated balance sheet.